# Naamit K. Gerber

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/naamit-k-gerber/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,990 |
| Field | Breast Cancer Treatment Studies |
| h-index | 22 |
| i10-index | 34 |
| Last Known Institution | NYU Langone Health |
| OpenAlex ID | https://openalex.org/A5020607218 |
| ORCID iD | 0000-0002-6061-0498 |
| Works | 186 |

## Researcher papers

- [Management of Brain Metastases in Tyrosine Kinase Inhibitor–Naïve Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis](https://scholariq.org/papers/management-of-brain-metastases-in-tyrosine-kinase-inhibitor-naive-epidermal/)
- [Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline](https://scholariq.org/papers/partial-breast-irradiation-for-patients-with-early-stage-invasive-breast-cancer/)
- [The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists](https://scholariq.org/papers/the-implications-of-genetic-testing-on-radiation-therapy-decisions-a-guide-for/)
- [Erlotinib Versus Radiation Therapy for Brain Metastases in Patients With EGFR-Mutant Lung Adenocarcinoma](https://scholariq.org/papers/erlotinib-versus-radiation-therapy-for-brain-metastases-in-patients-with-egfr/)
- [Adult Rhabdomyosarcoma Survival Improved With Treatment on Multimodality Protocols](https://scholariq.org/papers/adult-rhabdomyosarcoma-survival-improved-with-treatment-on-multimodality/)
- [Transcriptional diversity of long-term glioblastoma survivors](https://scholariq.org/papers/transcriptional-diversity-of-long-term-glioblastoma-survivors/)
- [Ipilimumab and whole brain radiation therapy for melanoma brain metastases](https://scholariq.org/papers/ipilimumab-and-whole-brain-radiation-therapy-for-melanoma-brain-metastases/)
- [The Clinical Utility of DCISionRT® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery](https://scholariq.org/papers/the-clinical-utility-of-dcisionrt-on-radiation-therapy-decision-making-in/)
- [Enhancement of 5-Fluorouracil-induced <i>In Vitro</i> and <i>In Vivo</i> Radiosensitization with MEK Inhibition](https://scholariq.org/papers/enhancement-of-5-fluorouracil-induced-i-in-vitro-i-and-i-in-vivo-i/)
- [Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal Micrometastases](https://scholariq.org/papers/post-mastectomy-radiation-therapy-in-breast-cancer-patients-with-nodal/)
- [Ipsilateral breast tumor recurrence in early stage breast cancer patients treated with breast conserving surgery and adjuvant radiation therapy: Concordance of biomarkers and tumor location from primary tumor to in-breast tumor recurrence](https://scholariq.org/papers/ipsilateral-breast-tumor-recurrence-in-early-stage-breast-cancer-patients/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Advanced Radiotherapy Techniques](https://scholariq.org/topics/advanced-radiotherapy-techniques/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)
- [Effects of Radiation Exposure](https://scholariq.org/topics/effects-of-radiation-exposure/)

## Researcher university

- [NYU Langone Health](https://scholariq.org/institutions/nyu-langone-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.